Insider Stock Trading History of Chin Richard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Chin Richard since year 2005. The trader's CIK number is 1337252. At the time of this reporting, Chin Richard is the President and CEO of Kindred Biosciences, Inc. . (stock ticker symbol KIN). See this page for all insider trading activities at Kindred Biosciences, Inc. .

Note that in the past Chin Richard also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Chin Richard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-01 KIN Kindred Biosciences, Inc. Sale 40,000 10.13 405,200
2018-05-30 KIN Kindred Biosciences, Inc. Sale 12,610 10.00 126,100
2018-05-24 KIN Kindred Biosciences, Inc. Sale 60 10.00 600
2018-05-25 KIN Kindred Biosciences, Inc. Sale 3,000 10.00 30,000
2018-05-18 KIN Kindred Biosciences, Inc. Sale 2,400 10.00 24,000
2018-05-07 KIN Kindred Biosciences, Inc. Sale 1,730 10.01 17,317
2018-05-09 KIN Kindred Biosciences, Inc. Sale 200 10.00 2,000
2018-05-01 KIN Kindred Biosciences, Inc. Sale 20,000 9.05 181,000
2018-04-02 KIN Kindred Biosciences, Inc. Sale 20,000 8.39 167,800
2017-07-03 KIN Kindred Biosciences, Inc. Sale 13,000 8.26 107,380
2017-06-22 KIN Kindred Biosciences, Inc. Sale 13,000 7.75 100,750
2014-02-12 GALE Rxi Pharmaceuticals Corp Sale 187,500 4.33 812,437
2014-02-12 GALE Rxi Pharmaceuticals Corp Option Ex 187,500 1.73 324,937
2014-01-30 GALE Rxi Pharmaceuticals Corp Option Ex 75,000 .79 58,875
2014-01-30 GALE Rxi Pharmaceuticals Corp Sale 75,000 5.59 419,250
2006-09-15 OXGN Mateon Therapeutics Inc Buy 45,464 4.08 185,629
2006-08-01 OXGN Mateon Therapeutics Inc Buy 20,000 3.29 65,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chin Richard (President and CEO of Kindred Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.